Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Neuroscience Letters|December 3, 2014
Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actionsDavid H Malin, Mallori M Henceroth, Jonathan J Izygon, et al.European Journal of Pharmacology|June 21, 2008
The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferationJakob Lerche Hansen, Mark Aplin, Jonas Tind Hansen, et al.The Journal of Biological Chemistry|November 20, 2008
Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer?Jakob L Hansen, Jonas T Hansen, Tobias Speerschneider, et al.European Journal of Pharmacology|December 12, 2022
Pimavanserin reverses multiple measures of anxiety in a rodent model of post-traumatic stress disorderDavid H Malin, Ping-Hsun Tsai, Joseph R Campbell, et al.Current Pharmaceutical Design|May 23, 2006
Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readoutEthan S Burstein, Fabrice Piu, Jian-Nong Ma, et al.Journal of Neurochemistry|December 5, 2020
Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer's diseaseCarla M Yuede, Clare E Wallace, Todd A Davis, et al.Molecular Pharmacology|May 4, 2007
Identification of the atypical L-type Ca2+ channel blocker diltiazem and its metabolites as ghrelin receptor agonistsJian-Nong Ma, Hans H Schiffer, Anne E Knapp, et al.Journal of Medicinal Chemistry|November 1, 2002
Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)Glenn E Croston, Roger Olsson, Erika A Currier, et al.Bioorganic & Medicinal Chemistry Letters|April 19, 2026
Discovery of novel SSRIs for a combination-treatment with pimavanserinAnnika Kers, Bálint Gabos, Sanjay Borhade, et al.Biochemical Pharmacology|September 2, 2008
Identification of novel selective V2 receptor non-peptide agonistsAndria L Del Tredici, Kim E Vanover, Anne E Knapp, et al.Pageof 6